Tectonic Therapeutic, Stock EBITDA
| TECX Stock | 50.54 2.98 6.27% |
Tectonic Therapeutic, fundamentals help investors to digest information that contributes to Tectonic Therapeutic,'s financial success or failures. It also enables traders to predict the movement of Tectonic Stock. The fundamental analysis module provides a way to measure Tectonic Therapeutic,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tectonic Therapeutic, stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -43.2 M | -45.3 M |
Tectonic | EBITDA |
Tectonic Therapeutic, Company EBITDA Analysis
Tectonic Therapeutic,'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Tectonic Therapeutic, EBITDA | (43.17 M) |
Most of Tectonic Therapeutic,'s fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tectonic Therapeutic, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tectonic EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Tectonic Therapeutic, is extremely important. It helps to project a fair market value of Tectonic Stock properly, considering its historical fundamentals such as EBITDA. Since Tectonic Therapeutic,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tectonic Therapeutic,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tectonic Therapeutic,'s interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Tectonic Ebitda
According to the company disclosure, Tectonic Therapeutic, reported earnings before interest,tax, depreciation and amortization of (43.17 Million). This is 104.92% lower than that of the Biotechnology sector and 143.1% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.11% higher than that of the company.
Tectonic EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tectonic Therapeutic,'s direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tectonic Therapeutic, could also be used in its relative valuation, which is a method of valuing Tectonic Therapeutic, by comparing valuation metrics of similar companies.Tectonic Therapeutic, is currently under evaluation in ebitda category among its peers.
Tectonic Therapeutic, Current Valuation Drivers
We derive many important indicators used in calculating different scores of Tectonic Therapeutic, from analyzing Tectonic Therapeutic,'s financial statements. These drivers represent accounts that assess Tectonic Therapeutic,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Tectonic Therapeutic,'s important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 552.2M | 504.7M | 165.0M | 31.1M | 60.3M | 57.3M | |
| Enterprise Value | 365.2M | 245.0M | (9.6M) | (45.3M) | 35.9M | 34.1M |
Tectonic Fundamentals
| Current Valuation | 83.39 M | ||||
| Shares Outstanding | 14.73 M | ||||
| Shares Owned By Insiders | 39.39 % | ||||
| Shares Owned By Institutions | 43.43 % | ||||
| Number Of Shares Shorted | 476.84 K | ||||
| Price To Book | 1.59 X | ||||
| EBITDA | (43.17 M) | ||||
| Net Income | (42.82 M) | ||||
| Total Debt | 4.34 M | ||||
| Book Value Per Share | 11.29 X | ||||
| Cash Flow From Operations | (40.68 M) | ||||
| Short Ratio | 1.44 X | ||||
| Earnings Per Share | (3.07) X | ||||
| Target Price | 60.0 | ||||
| Number Of Employees | 44 | ||||
| Market Capitalization | 265.07 M | ||||
| Total Asset | 101.09 M | ||||
| Retained Earnings | (477.27 M) | ||||
| Working Capital | 29.2 M | ||||
| Net Asset | 101.09 M |
About Tectonic Therapeutic, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tectonic Therapeutic,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tectonic Therapeutic, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tectonic Therapeutic, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.